Trademark: 97108305
Word
PHAGEFINITY
Status
Dead
Status Code
606
Status Date
Monday, May 29, 2023
Serial Number
97108305
Mark Type
4000
Filing Date
Thursday, November 4, 2021
Published for Opposition
Tuesday, August 30, 2022
Abandoned Date
Monday, May 29, 2023

Trademark Owner History
Adaptive Phage Therapeutics, Inc. - Owner At Publication

Classifications
40 custom manufacture of pharmaceuticals in the nature of bacteriophage therapeutics for others
9 Computer software system comprised of downloadable computer software for identifying precision therapy for treatment of bacterial infections
5 human, animal, plant and microorganism biological preparations for disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the field of medicine; diagnostic kits comprised of medical diagnostic reagents for testing bacteria sensitivity; diagnostic kits comprising medical diagnostic reagents for testing bacteria sensitivity
1 diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising diagnostic reagents for testing bacteria sensitivity, except for medical or veterinary use; human, animal, plant and microorganism biological preparations for use in industry and science, namely, for use in drug development; biological preparations for use in industry and science, namely, for treating bacterial contamination in the fields of farming and food preparation; biological preparations for use in industry and science, namely, for treating bacterial contamination in the industrial and food preparation fields
11 Refrigerators and freezers for medical storage purposes
44 medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes, namely, providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; medical consulting services in the field of medical diagnostic and prognostic testing; medical services in the nature of medical analysis services for diagnostic and prognostic testing and treatment purposes; medical services in the nature of providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of a person; medical testing and medical diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
42 new product research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and pharmaceuticals; medical laboratory services and scientific laboratory services in the nature of clinical and medical laboratory testing services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom biochemical assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; new product research and development of vaccines and therapeutics; providing temporary use of online non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; medical research, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; laboratory research services in the field of microbiological laboratory testing of bacteria for research purposes and technical consultation relating thereto; scientific and medical research, in particular, design and development of diagnostic assays; medical laboratory services in the nature of testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; medical laboratory services in the nature of microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto
PHAGE FINITY

Trademark Events
May 30, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 29, 2023
Abandonment - No Use Statement Filed
Apr 4, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 4, 2023
Teas Change Of Correspondence Received
Apr 4, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 4, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 4, 2023
Teas Change Of Owner Address Received
Oct 25, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 30, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2022
Published For Opposition
Aug 10, 2022
Notification Of Notice Of Publication E-Mailed
Jul 26, 2022
Approved For Pub - Principal Register
Jul 26, 2022
Examiner's Amendment Entered
Jul 26, 2022
Notification Of Examiners Amendment E-Mailed
Jul 26, 2022
Examiners Amendment E-Mailed
Jul 26, 2022
Examiners Amendment -Written
Jul 20, 2022
Assigned To Examiner
Nov 15, 2021
New Application Office Supplied Data Entered
Nov 8, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24